Vaxart, Inc. ( VXRT) - Key Metrics
VXRT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.11 | -$0.06 | $0.01 | $0.01 |
| 2026Q1 | $0.16 | $0.02 | -$0.01 | -$0.01 |
| 2025Q4 | $0.45 | $0.24 | $0.13 | $0.13 |
| 2025Q3 | $0.32 | -$0.04 | $0.01 | $0.01 |
| 2025Q2 | $0.17 | -$0.07 | -$0.07 | -$0.07 |
VXRT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.53 |
| 2026Q1 | 0% | 7.63 |
| 2025Q4 | 0% | 0.38 |
| 2025Q3 | 0% | -2.25 |
| 2025Q2 | 0% | -1.61 |
VXRT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.86% | 0% |
| 2026Q1 | -1.70% | 0% |
| 2025Q4 | 38.04% | 0% |
| 2025Q3 | 3.01% | 0% |
| 2025Q2 | -15.35% | 0% |
VXRT
Price: $0.51
52 week price:
Earnings Per Share: 0.17 USD
P/E Ratio: 3.35
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Ebitda: -2.9 millionMarket Capitalization: 101.7 million